Scientists mapped how a brain‑cell receptor called FPR2 grabs the harmful amyloid‑beta peptide linked to Alzheimer’s and how it also binds the protective peptide humanin. This structural map shows two key spots on the receptor that recognize these molecules, giving clues for future drug design, but it doesn’t change any current supplement or lifestyle advice.

Formyl peptide receptor 2 (FPR2) has been shown to mediate the cytotoxic effects of the β amyloid peptide Aβ₄₂ and serves as a receptor for humanin, a peptide that protects neuronal cells from damage by Aβ₄₂, implying its involvement in the pathogenesis of Alzheimer's disease (AD). However, the interaction pattern between FPR2 and Aβ₄₂ or humanin remains unknown. Here we report the structures of FPR2 bound to G_i and Aβ₄₂ or N-formyl humanin (fHN). Combined with functional data, the structures reveal two critical regions that govern recognition and activity of Aβ₄₂ and fHN, including a polar binding cavity within the receptor helical bundle and a hydrophobic binding groove in the extracellular region. In addition, the structures of FPR2 and FPR1 in complex with different formyl peptides were determined, providing insights into ligand recognition and selectivity of the FPR family. These findings uncover key factors that define the functionality of FPR2 in AD and other inflammatory diseases and would enable drug development.